Bridgeway Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$273K Hold
2022
Q4
$182K Buy
2022
Q3
$237K Buy
2022
Q2
$285K Hold
2022
Q1
$272K Buy